Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide in the Adjuvant Treatment of Moderate COVID-19 Pneumonia
NCT04273529Phase 2Unknown
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Feb 2020
- Primary completion
- May 2020
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of thalidomide in coronavirus disease 2019 (COVID-19), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Status: unknown.
02
Drugs
thalidomide
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04273529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04273529.